Neutrophil Heterogeneity and the Limits of Blood Summaries

Authors

  • Troy Spencer Author
  • Dustin Lawson Author
  • Travis Gardner Author

Abstract

This conceptual analysis examines aggregation in immune-state and tumor evidence synthesis, using cell states, splenic activity, treatment resistance as the key comparison axes. A bounded review of the literature is used to formulate, rather than claim to complete, an evaluation. The focal evidence concerns why autoimmune activity can persist or recur when conventional inflammation suppression does not durably change underlying cellular and tissue states. Aggregation improves convenience at the cost of distinctions. A cell count, mean signal, or overall score can mask mixtures with different functions. Inspect component distributions and compare conclusions before and after pooling. Preserve interpretable strata where they change the mechanism or decision. The proposed comparison concerns cell states, splenic activity, treatment resistance; it would test whether the specific failure scenario is detected without erasing legitimate uncertainty. Implications are restricted to the evidence roles relevant to immune-state and tumor evidence synthesis, leaving broader efficacy and deployment claims unresolved.

References

Yu, Xiao, et al. “Resetting Immunometabolic Set Points in Autoimmune Disease.” Journal of Translational Autoimmunity, vol. 13, 2026, https://doi.org/10.1016/j.jtauto.2026.100391.

Guo, Qian, et al. “Immune Niches in Brain Tumors: Glial–Immune Cell Interactions and Spatial Microdomains.” Acta Neuropathologica Communications, vol. 14, 2026, https://doi.org/10.1186/s40478-026-02373-0.

Zhang, Yidan, et al. “Splenic Extramedullary Granulopoiesis and Neutrophil States in Cancer Immunity: Systemic Immunosuppression and Therapeutic Resistance.” Cancer Bioscience, 2026, https://doi.org/10.1016/j.cbs.2026.100009.

Gao, Bibo, et al. “The Prediction of Extended Hospital Length of Stay in Patients after Endoscopic Endonasal Transsphenoidal Surgery for the Resection of Non-Functioning Pituitary Adenomas: A Dual-Center Retrospective Analysis.” Cancers, vol. 18, no. 10, 2026, https://doi.org/10.3390/cancers18101582.

Geifman, Yonatan, and Ran El-Yaniv. “Selective Classification for Deep Neural Networks.” Advances in Neural Information Processing Systems, vol. 30, 2017.

Lundberg, Scott M., and Su-In Lee. “A Unified Approach to Interpreting Model Predictions.” Advances in Neural Information Processing Systems, vol. 30, 2017.

World Health Organization. Ethics and Governance of Artificial Intelligence for Health. World Health Organization, 2021.

National Academies of Sciences, Engineering, and Medicine. Reproducibility and Replicability in Science. National Academies Press, 2019.

Wilkinson, Mark D., et al. “The FAIR Guiding Principles for Scientific Data Management and Stewardship.” Scientific Data, vol. 3, 2016, article 160018.

Hernán, Miguel A., and James M. Robins. Causal Inference: What If. Chapman & Hall/CRC, 2020.

Rothman, Kenneth J., Sander Greenland, and Timothy L. Lash. Modern Epidemiology. 3rd ed., Lippincott Williams & Wilkins, 2008.

Benjamini, Yoav, and Yosef Hochberg. “Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing.” Journal of the Royal Statistical Society: Series B, vol. 57, no. 1, 1995, pp. 289–300.

Rajkomar, Alvin, Jeffrey Dean, and Isaac Kohane. “Machine Learning in Medicine.” New England Journal of Medicine, vol. 380, 2019, pp. 1347–58.

Wiens, Jenna, et al. “Do No Harm: A Roadmap for Responsible Machine Learning for Health Care.” Nature Medicine, vol. 25, 2019, pp. 1337–40.

Downloads

Published

2026-10-14

Issue

Section

Reviews and Perspectives